Only buyers in this multibagger penny stock under Rs 10; announces stellar quarterly results with a 4,564 per cent jump in revenue!
The stock gave multibagger returns of 104 per cent in just 2 years and over 320 per cent in 3 years.
On Wednesday, one of the Top Gainers on BSE, shares of Tilak Ventures Ltd jumped 20 per cent upper circuit to Rs 5.08 per share from its previous closing of Rs 4.24. At the closing bell, shares of the company were trading at Rs 5.04 per share, up 18.87 per share with a spurt in volume by more than 7.71 times on BSE.
Tilak Ventures Ltd is engaged in finance business and commodity trading. The company was also interested in the power project business. The company announced its Quarterly Results ended June 30, 2023, which was the main reason for the sudden rise in stock price. Here are the details:
Financial Highlights for the Q1FY24:
- Net sales stood at Rs 5.13 crore, up 4,564 per cent compared to Q1FY23.
- Operating profit stood at Rs 0.51 crore, up 304 per cent compared to Q1FY24
- Profit before tax stood at Rs 1.46 crore (including other income of Rs 0.95 crore), up 595 per cent compared to Q1FY23.
- Profit After Tax of Rs 1.06 crore, up 783 per cent compared to Q1FY23.
- The EPS for Q1FY24 stood at Rs 0.05 compared to Rs 0.01 in Q1FY23, an increase of 400 per cent.
Want more insightful stories along with recommendations?
Get a 3-month subscription to experience the power of our flagship DSIJ Magazine (online edition) for just Rs 800/- Click here to subscribe now
The company has a market cap of Rs 112.31 crore with a 3-year stock price CAGR of 53 per cent. Additionally, the company has very little debt, with only Rs 2.45 crore outstanding. This is just 2.18 per cent of its current market capitalization, which means that the company is essentially debt-free.
The stock gave multibagger returns of 104 per cent in just 2 years and over 320 per cent in 3 years. Investors should keep an eye on this micro-cap stock.
Disclaimer: The article is for informational purposes only and not investment advice.